Page 4 - Myopia Control News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, according to a randomized controlled trial conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and funded by the National Eye Institute (NEI). The trial aimed to identify an effective way to manage this leading and increasingly common cause of refractive error, which can cause serious uncorrectable vision loss later in life. Results from the trial were published in JAMA Ophthalmology.

Malcolmm marquisKatherinek weiseMichaelx repkaMichaelf chiangHealth researchUniversity of alabama at birminghamMethod of researchJaeb centerNational institutes of healthNational eye institute institutes of healthPediatric eye disease investigator groupHuman servicesFund for innovationJohns hopkins universityResearch to prevent blindnessDiscovery into health